Cell News and Research

RSS

New online tool helps educate practicing oncologists with therapeutic decision-making for NSCLC

A new interactive online tool helps educate practicing oncologists worldwide with therapeutic decision-making for advanced non-small cell lung cancer (NSCLC) based on a patient's molecular and clinical characteristics by providing feedback from an expert panel.

26 Feb 2015

Simple urine test could guide clinicians to better treat bladder cancer patients

Researchers at the University of Birmingham believe that a simple urine test could help to guide clinicians in the treatment of bladder cancer patients.

26 Feb 2015

Researchers one step closer to understanding development of glioblastoma

Glioblastomas are a highly aggressive type of brain tumor, with few effective treatment options. Moffitt Cancer Center researchers are one step closer to understanding glioblastoma development following the identification of a key protein signaling pathway involved in brain tumor stem cell growth and survival.

26 Feb 2015

Metrohm USA announces 2015 Young Chemist Award winner

Metrohm USA and Metrohm Canada are pleased to announce the winner of the 2015 Young Chemist Award, Chad Atkins. Chad is completing his Ph.D. at the University of British Columbia where he works under the supervision of Robin Turner and Michael Blades.

26 Feb 2015

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

ABIVAX, a clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, today announced that it has dosed in New Zealand the first patient in a Phase IIb/III clinical trial of ABX203 which is taking place in several countries of the Asia-Pacific region.

26 Feb 2015

Bruker-sponsored sixth AFM Biomed conference highlights increasing impact of AFM in biological applications

Bruker recently sponsored the sixth AFM BioMed International Meeting on AFM in Life Sciences and NanoMedicine. Held last month at the Sanford Consortium for Regenerative Medicine in La Jolla, CA, the conference brought together more than 125 scientists from around the world.

From Bruker Nano Surfaces and Metrology 26 Feb 2015

Unique research consortium focuses on musculoskeletal disorders and diseases

The Kansas City University of Medicine and Biosciences, the University of Missouri – Kansas City and the University of Kansas Medical Center proudly announce a research consortium among the three Kansas City-area institutions. The consortium brings together scientists and resources focused on the research of musculoskeletal disorders and diseases.

26 Feb 2015

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Paola Leone, PhD, the director of the Cell and Gene Therapy Center and a professor of Cell Biology at the Rowan University School of Osteopathic Medicine, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child's life by age 10.

26 Feb 2015

Scientists find new links between inflammation and tissue regeneration

Almost all injuries, even minor skin scratches, trigger an inflammatory response, which provides protection against invading microbes but also turns on regenerative signals needed for healing and injury repair - a process that is generally understood but remains mysterious in its particulars.

26 Feb 2015

Fat cell transplantation benefits systemic sclerosis patients with non-healing digital ulcers

Digital ulcers (DUs) are a frequent, painful, and quality of life altering complication for patients with systemic sclerosis (SSc), a connective tissue disease causing a progressive loss of small blood vessels and resulting changes in organs and tissues. DUs on the fingertips of SSc patients are slow to heal, if they heal at all, as many are unresponsive to any therapies.

26 Feb 2015

U of T Scarborough professor develops new compound that can lead to cheaper anti-cancer drugs

A new compound developed at the University of Toronto Scarborough could play an important role in developing cheaper anti-cancer drugs.

26 Feb 2015

Scientists discover DNA vaccine that alleviates chronic inflammation in the body

An international team of scientists including CureLab Oncology, Inc. (Boston), University of Camerino (Italy), and Boston University have serendipitously discovered a DNA vaccine, which systemically alleviates chronic inflammation in the body. Since osteoporosis is an inflammatory disease, preventive and therapeutic effects of the new vaccine were demonstrated on mouse models with osteoporosis.

26 Feb 2015

Tolero's alvocidib receives EMA orphan drug designation for treatment of AML patients

Tolero Pharmaceuticals, Inc., a clinical-stage company developing treatments for serious hematological diseases, today announced that the European Medicines Agency has granted orphan drug designation for alvocidib for the treatment of patients with acute myeloid leukemia (AML).

26 Feb 2015

Researchers reveal how malaria parasite deploys genetic trickery to escape immune system attack

Up to one million people -- mainly pregnant woman and young children -- are killed each year by the Plasmodium falciparum parasite, which causes the most devastating form of human malaria.

26 Feb 2015

Scientists use graphene to target, neutralise cancer stem cells

University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells.

25 Feb 2015

Researchers identify previously unknown effect of vitamin A in embryonic development

Researchers at Lund University in Sweden have identified a previously unknown effect of vitamin A in human embryonic development. Their findings show that vitamin A affects the formation of blood cells.

25 Feb 2015

Premature infants with retinal swelling face neuro-developmental issues

Using a portable, non-invasive imaging device, a team of Duke Medicine doctors have identified swelling in the back of the eyes of premature infants that correlates with poorer neurodevelopment as the babies grow.

25 Feb 2015

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

Findings from a federally funded study suggest that patients with locally advanced kidney cancer should not be treated with either adjuvant (post-surgery) sorafenib or sunitinib. The average period to disease recurrence was similar between those who received sorafenib or sunitinib after surgery (5.6 years) and those treated with placebo (5.7 years).

25 Feb 2015

New TAU study may offer hope to people diagnosed with Glioblastoma multiforme

There are no effective available treatments for sufferers of Glioblastoma multiforme (GBM), the most aggressive and devastating form of brain tumor. The disease, always fatal, has a survival rate of only 6-18 months.

25 Feb 2015

Scientists detect new molecule that contributes to development of liver fibrosis

Liver fibrosis, which is the progressive formation of scar tissue in the liver, is a massive medical problem. An estimated ten percent of the population is affected by liver fibrosis or its corresponding later stage, liver cirrhosis. A variety of causes can lead to liver fibrosis, the most widely recognized ones being alcohol consumption and virus-induced chronic liver inflammation.

25 Feb 2015

Cell News and Research

New online tool helps educate practicing oncologists with therapeutic decision-making for NSCLC

Simple urine test could guide clinicians to better treat bladder cancer patients

Researchers one step closer to understanding development of glioblastoma

Metrohm USA announces 2015 Young Chemist Award winner

ABIVAX doses first patient in ABX203 Phase IIb/III trial for treatment of chronic hepatitis B

Bruker-sponsored sixth AFM Biomed conference highlights increasing impact of AFM in biological applications

Unique research consortium focuses on musculoskeletal disorders and diseases

RowanSOM researcher awarded NINDS grant to develop stem cell-based therapy for Canavan disease

Scientists find new links between inflammation and tissue regeneration

Fat cell transplantation benefits systemic sclerosis patients with non-healing digital ulcers

U of T Scarborough professor develops new compound that can lead to cheaper anti-cancer drugs

Scientists discover DNA vaccine that alleviates chronic inflammation in the body

Tolero's alvocidib receives EMA orphan drug designation for treatment of AML patients

Researchers reveal how malaria parasite deploys genetic trickery to escape immune system attack

Scientists use graphene to target, neutralise cancer stem cells

Researchers identify previously unknown effect of vitamin A in embryonic development

Premature infants with retinal swelling face neuro-developmental issues

Sorafenib, sunitinib provide no benefit to patients with locally advanced kidney cancer

New TAU study may offer hope to people diagnosed with Glioblastoma multiforme

Scientists detect new molecule that contributes to development of liver fibrosis

What are the challenges of cell line development? eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring